RAFAVE Trademark

Trademark Overview

On Friday, January 14, 2011, a trademark application was filed for RAFAVE with the United States Patent and Trademark Office. The USPTO has given the RAFAVE trademark a serial number of 85218098. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 22, 2014. This trademark is owned by Glaxo Group Limited. The RAFAVE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines
rafave

General Information

Serial Number85218098
Word MarkRAFAVE
Filing DateFriday, January 14, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 22, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 21, 2011

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 20, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Monday, September 22, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, September 22, 2014ABANDONMENT - NO USE STATEMENT FILED
Friday, January 17, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 16, 2014EXTENSION 5 GRANTED
Friday, January 3, 2014EXTENSION 5 FILED
Friday, January 3, 2014TEAS EXTENSION RECEIVED
Thursday, June 13, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 12, 2013EXTENSION 4 GRANTED
Tuesday, June 11, 2013EXTENSION 4 FILED
Tuesday, June 11, 2013TEAS EXTENSION RECEIVED
Monday, March 25, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 25, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, January 25, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 24, 2013EXTENSION 3 GRANTED
Thursday, January 17, 2013EXTENSION 3 FILED
Thursday, January 17, 2013TEAS EXTENSION RECEIVED
Tuesday, August 14, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 13, 2012EXTENSION 2 GRANTED
Friday, July 27, 2012EXTENSION 2 FILED
Monday, August 13, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, July 27, 2012TEAS EXTENSION RECEIVED
Wednesday, January 18, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 16, 2012EXTENSION 1 GRANTED
Monday, January 16, 2012EXTENSION 1 FILED
Monday, January 16, 2012TEAS EXTENSION RECEIVED
Tuesday, August 16, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 21, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 21, 2011PUBLISHED FOR OPPOSITION
Wednesday, May 18, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, May 18, 2011ASSIGNED TO LIE
Wednesday, May 4, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 3, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 3, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 3, 2011TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, March 31, 2011NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, March 31, 2011LETTER OF SUSPENSION E-MAILED
Thursday, March 31, 2011SUSPENSION LETTER WRITTEN
Wednesday, March 30, 2011ASSIGNED TO EXAMINER
Thursday, January 20, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, January 18, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

rafave pharmaceutical treatment substances disorders preparations diseases hormonal neurological gastrointestinal ophthalmic